Fundraising Fox
/Companies
Sign in

BioStream Technologies

West Chester, US · Founded 2015 · Delaware LLC

Find your way into BioStream Technologies

Each arrow is one introduction. Sign up to fill in the first one.

92 people can intro you to Harry

Ask Brian Butler to introduce you to Harry G. Schiavi

You →Brian · together at Insight Strategy Advisors →Harry

Sign up to find every way you can get introduced to BioStream Technologies

  • Your email: who you already know at BioStream Technologies, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioStream Technologies team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Biostream Technologies develops interactive, evidence-based adjunctive therapies for children with autism, designed to improve eye contact, visual behavior, attention, and emotion recognition. The company serves therapists and special education professionals treating autistic children.

Digital HealthEdTechHealthtechMedical Devices

Founders & leadership

SCStephen Clark
Stephen ClarkVice President
MFMichael Farber
Michael FarberVice President
HGHarry G. Schiavi
Harry G. SchiaviCEOHarry G. Schiavi is CEO of BioStream Technologies, an autism therapy startup. He previously ran a consulting firm advising pharmaceutical and biotechnology companies on commercialization, market access, pricing, and reimbursement.
RKRobert K. Ross
Robert K. RossVice President of Clinical Development and Integration
TMThomas McCaffery
Thomas McCafferyGeneral Counsel

Reported raises · per SEC filings

Form D private placements

$2.2M disclosed across 6 rounds · 2017–2024

▶$150KraisedJul 2024 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen ClarkExecutive Officer
  • Michael FarberExecutive Officer
  • Harry SchiaviExecutive Officer
Offering amount
$150K
Amount sold
$150K
First sale
Jul 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200KraisedApr 2024 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael FarberExecutive Officer
  • Stephen ClarkExecutive Officer
  • Harry SchiaviExecutive Officer
Offering amount
$200K
Amount sold
$200K
First sale
Apr 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedMar 2024 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael FarberExecutive Officer
  • Stephen ClarkExecutive Officer
  • Harry SchiaviExecutive Officer
Offering amount
$150K
Amount sold
$150K
First sale
Feb 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$875KraisedDec 2022 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael FarberExecutive Officer
  • Stephen ClarkExecutive Officer
  • Harry SchiaviExecutive Officer
Offering amount
$3M
Amount sold
$875K
First sale
Oct 2022
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$800KraisedAug 2021 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Harry SchiaviExecutive Officer, Director
  • Stephen ClarkExecutive Officer, Director
  • Michael FarberExecutive Officer, Director
Offering amount
$1M
Amount sold
$800K
Minimum investment
$50K
First sale
Dec 2018
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45KraisedSep 2017 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael FarberExecutive Officer
Offering amount
$45K
Amount sold
$45K
Minimum investment
$45K
First sale
Jun 2017
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase ISTTR2018$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does BioStream Technologies do?
Biostream Technologies develops interactive, evidence-based adjunctive therapies for children with autism, designed to improve eye contact, visual behavior, attention, and emotion recognition. The company serves therapists and special education professionals treating autistic children.
How much funding has BioStream Technologies raised?
BioStream Technologies has disclosed $2.2M raised across 6 rounds.
Where is BioStream Technologies headquartered?
BioStream Technologies is headquartered in West Chester, US.